HHS Awards $4.1M for HIV Diagnostics Commercialization, Boosting Innovation
Contract Overview
Contract Amount: $4,141,610 ($4.1M)
Contractor: National Collegiate Inventors & Innovators Alliance, Inc.
Awarding Agency: Department of Health and Human Services
Start Date: 2024-05-28
End Date: 2027-06-30
Contract Duration: 1,128 days
Daily Burn Rate: $3.7K/day
Competition Type: FULL AND OPEN COMPETITION
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: RADX INNOVATION FUNNEL FOR HIV DIAGNOSTICS - COMMERCIALIZATION CENTER
Place of Performance
Location: HADLEY, HAMPSHIRE County, MASSACHUSETTS, 01035
Plain-Language Summary
Department of Health and Human Services obligated $4.1 million to NATIONAL COLLEGIATE INVENTORS & INNOVATORS ALLIANCE, INC. for work described as: RADX INNOVATION FUNNEL FOR HIV DIAGNOSTICS - COMMERCIALIZATION CENTER Key points: 1. Significant investment in HIV diagnostics commercialization. 2. Competition method is 'Full and Open', suggesting broad market engagement. 3. Risk is moderate due to the innovation and commercialization phase. 4. Sector focus is on healthcare technology and public health solutions.
Value Assessment
Rating: good
The award amount of $4.1M appears reasonable for a project focused on commercializing innovative diagnostics. Benchmarking against similar R&D and commercialization contracts would provide further context on pricing.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, which typically fosters competitive pricing and allows for the best value to be identified. This method is ideal for seeking innovative solutions.
Taxpayer Impact: This investment aims to accelerate the availability of advanced HIV diagnostics, potentially leading to improved public health outcomes and reduced long-term healthcare costs.
Public Impact
Accelerates development of new HIV diagnostic tools. Supports innovation in public health and disease prevention. Potential for improved patient outcomes and reduced transmission rates. Fosters growth in the health technology sector.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Commercialization risk for innovative products.
- Dependence on successful market adoption.
- Potential for long development timelines.
Positive Signals
- Addresses a critical public health need.
- Utilizes a competitive procurement process.
- Supports technological advancement in diagnostics.
Sector Analysis
This contract falls within the healthcare and R&D sectors, specifically focusing on medical diagnostics. Spending in this area is crucial for advancing public health initiatives and combating diseases like HIV.
Small Business Impact
While the contract details do not explicitly mention small business participation, the 'Full and Open' competition method theoretically allows for small businesses to compete if they possess the required capabilities.
Oversight & Accountability
The National Institutes of Health (NIH) is responsible for overseeing this award, ensuring that funds are used effectively to achieve the project's goals of commercializing HIV diagnostics.
Related Government Programs
- Other Management Consulting Services
- Department of Health and Human Services Contracting
- National Institutes of Health Programs
Risk Flags
- Innovation risk
- Market adoption uncertainty
- Regulatory hurdles
- Long-term funding sustainability beyond this award
Tags
other-management-consulting-services, department-of-health-and-human-services, ma, delivery-order, 1m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $4.1 million to NATIONAL COLLEGIATE INVENTORS & INNOVATORS ALLIANCE, INC.. RADX INNOVATION FUNNEL FOR HIV DIAGNOSTICS - COMMERCIALIZATION CENTER
Who is the contractor on this award?
The obligated recipient is NATIONAL COLLEGIATE INVENTORS & INNOVATORS ALLIANCE, INC..
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (National Institutes of Health).
What is the total obligated amount?
The obligated amount is $4.1 million.
What is the period of performance?
Start: 2024-05-28. End: 2027-06-30.
What is the expected timeline for commercialization and market entry of the diagnostics developed under this award?
The contract period extends to June 2027, suggesting that significant progress towards commercialization is expected within this timeframe. However, the specific timeline for market entry will depend on the success of the innovation funnel, regulatory approvals, and market adoption strategies developed by the awardee.
What are the key performance indicators (KPIs) used to measure the success of this commercialization effort?
Key performance indicators likely include milestones related to prototype development, testing, regulatory submissions, and ultimately, the successful launch and adoption of the diagnostic tools in the market. The specific KPIs would be detailed in the contract's statement of work and performance metrics.
How will the effectiveness of the awarded innovation funnel be evaluated in terms of its impact on HIV diagnostics availability?
Effectiveness will be evaluated by tracking the number and quality of diagnostics that successfully move through the funnel towards commercialization. Success metrics may include the speed of development, cost-effectiveness of the diagnostics, and their ability to meet unmet needs in HIV testing and diagnosis.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Management, Scientific, and Technical Consulting Services › Other Management Consulting Services
Product/Service Code: SUPPORT SVCS (PROF, ADMIN, MGMT) › PROFESSIONAL SERVICES
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: 100 VENTURE WAY STE 8, HADLEY, MA, 01035
Business Categories: Category Business, Corporate Entity Tax Exempt, Nonprofit Organization, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $4,141,610
Exercised Options: $4,141,610
Current Obligation: $4,141,610
Actual Outlays: $1,215,630
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Cost or Pricing Data: NO
Parent Contract
Parent Award PIID: 75N92022D00013
IDV Type: IDC
Timeline
Start Date: 2024-05-28
Current End Date: 2027-06-30
Potential End Date: 2027-09-25 00:00:00
Last Modified: 2026-01-12
More Contracts from National Collegiate Inventors & Innovators Alliance, Inc.
- Innovation Funnel for Covid19 - Commercialization Center — $50.5M (Department of Health and Human Services)
- Radx Innovation Funnel for Covid-19 - Award Management — $42.5M (Department of Health and Human Services)
- Rapid Acceleration of Diagnostics (radx) for Itap Consultants and Infrastructure Support — $33.4M (Department of Health and Human Services)
- Radx Innovation Funnel for Covid-19 - Award Management — $24.8M (Department of Health and Human Services)
- Rapid Acceleration of Diagnostics (radx) Clinical Evaluation Services -Task Order 06 — $22.3M (Department of Health and Human Services)
View all National Collegiate Inventors & Innovators Alliance, Inc. federal contracts →
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →